Pfizer Inc (NYSE:PFE)
$ 28.01 -0.17 (-0.6%) Market Cap: 158.72 Bil Enterprise Value: 215.50 Bil PE Ratio: 0 PB Ratio: 1.72 GF Score: 77/100

Pfizer Inc to Acquire Trillium Therapeutics Inc Call Transcript

Aug 23, 2021 / 02:00PM GMT
Release Date Price: $49.93 (+2.48%)
Operator

Good day, everyone, and welcome to Pfizer's Analyst and Investor Call to discuss proposed acquisition of Trillium Therapeutics Inc. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, Senior Vice President and Chief Investor Relations Officer. Please go ahead, sir.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

Thank you, Sylvia. Good morning, everyone, and thank you for joining us on short notice. It's my pleasure to be welcoming you to a call to discuss our acquisition of Trillium today. Turn to Slide 2, please. As you can see on the screen, we will be making forward-looking statements during the call regarding amongst other topics, our anticipated future operating and financial performance, business plans and prospects and expectations for our product pipeline and marketed products, which are subject to risks and uncertainties as well as the use of non-GAAP financial information.

Additional information regarding forward-looking statements and our non-GAAP financial measures is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot